<?xml version="1.0" encoding="UTF-8"?>
<fig id="ppat.1006934.g006" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.ppat.1006934.g006</object-id>
 <label>Fig 6</label>
 <caption>
  <title>DENV2 polyclonal antibodies target EDIII and EDI epitopes.</title>
  <p>Blockade of binding assay where DENV2 natural infection immune sera (A, B) or DENV2 monovalent vaccine sera (C, D), were assessed for their ability to block 2D22-AP (A, C) or 3F9-AP (B, D) from binding to their respective epitopes on DENV2. DENV immune sera were depleted of cross-reactive antibodies prior to blockade assay.</p>
 </caption>
 <graphic xlink:href="ppat.1006934.g006" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
